image of Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The SARS-CoV-2 virus has emerged and rapidly evolved into a current global pandemic. Although bacterial and fungal coinfections have been associated with COVID-19, little is known about parasitic infection. We report a case of a COVID-19 patient who developed disseminated strongyloidiasis following treatment with high-dose corticosteroids and tocilizumab. Screening for infection should be pursued in individuals with COVID-19 who originate from endemic regions before initiating immunosuppressive therapy.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

  • Received : 19 Jun 2020
  • Accepted : 10 Aug 2020
  • Published online : 14 Aug 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error